Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer.
Open Forum Infect Dis
; 7(2): ofaa038, 2020 Feb.
Article
in En
| MEDLINE
| ID: mdl-32099847
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Risk_factors_studies
Language:
En
Journal:
Open Forum Infect Dis
Year:
2020
Type:
Article
Affiliation country:
Germany